This post was originally published on this site
UnitedHealth announced earnings per share of $5.49 on revenue of $80.1B. Analysts polled by Investing.com anticipated EPS of $5.36 on revenue of $78.69B.
UnitedHealth shares are up 6% from the beginning of the year, still down 2.18% from its 52 week high of $548.97 set on April 8. They are outperforming the Dow Jones which is down 4.88% from the start of the year.
UnitedHealth’s report follows an earnings beat by BioNTech on March 30, who reported EPS of $12.18 on revenue of $5.53B, compared to forecasts EPS of $7.44 on revenue of $3.92B.
Legend Bio had beat expectations on March 18 with first quarter EPS of $-0.3 on revenue of $39M, compared to forecast for EPS of $-0.3418 on revenue of $14.27M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
